Global Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Tiziana Life Sciences

Market Cap: US$230.7m

A biotechnology company, engages in the development of transformative therapies for neurodegenerative and lung diseases in the United States.

Larimar Therapeutics

Market Cap: US$416.0m

A clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform.

Boiron

Market Cap: €506.1m

Manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally.

Stoke Therapeutics

Market Cap: US$1.3b

An early-stage biopharmaceutical company, engages in the development of treatments for severe genetic diseases by upregulating protein expression.

Oxford Nanopore Technologies

Market Cap: UK£1.4b

Engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows the real-time analysis of DNA or RNA.

Incyte

Market Cap: US$15.9b

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

Zura Bio

Market Cap: US$136.5m

A clinical-stage biotechnology company, develops medicines for immune and inflammatory disorders in the United States.

Erasca

Market Cap: US$513.4m

A clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers.

UCB

Market Cap: €37.4b

A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.

Skye Bioscience

Market Cap: US$111.6m

A clinical stage biopharmaceutical company, focuses on developing molecules that modulate G protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases.

Cidara Therapeutics

Market Cap: US$2.3b

Operates as a biotechnology company that focuses on developing targeted therapies for patients facing cancers and other serious diseases.

Sunshine Biopharma

Market Cap: US$6.9m

Operates as a pharmaceutical company that focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada.

Neurocrine Biosciences

Market Cap: US$14.1b

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally.

Spermosens

Market Cap: SEK 23.5m

Provides diagnostic health care products and services in Sweden.

Solid Biosciences

Market Cap: US$461.0m

Develops therapies for neuromuscular and cardiac diseases in the United States.

Aclaris Therapeutics

Market Cap: US$215.6m

A clinical-stage biopharmaceutical company, engages in the development of novel drug candidates for immune-inflammatory diseases in the United States.

Eledon Pharmaceuticals

Market Cap: US$161.1m

Operates as a clinical stage biotechnology company.

Supernus Pharmaceuticals

Market Cap: US$2.6b

A biopharmaceutical company, develops and commercializes products for the treatment of central nervous system (CNS) diseases in the United States.

Inhibitor Therapeutics

Market Cap: US$9.8m

A pharmaceutical development company, develops and commercializes therapeutics for patients with certain cancers and non-cancerous proliferation disorders in the United States.

Hexima

Market Cap: AU$2.2m

Does not have significant operations.

UnicoCell Biomed

Market Cap: NT$5.2b

Engages in the research and development of stem cell drugs, cell therapy technology, and regenerative medical services in Taiwan.

Dimerix

Market Cap: AU$306.1m

A biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia.

Zydus Lifesciences

Market Cap: ₹981.1b

Engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, and internationally.

Original BioMedicals

Market Cap: NT$746.4m

A biotechnology company, chemical entities to solve unmet medical needs in Taiwan.

Onconic Therapeutics

Market Cap: ₩584.2b

Engages in the research and development of anti-cancer therapy in South Korea.

Dong-E-E-JiaoLtd

Market Cap: CN¥30.6b

Engages in the research, development, production, and sale of donkey-hide gelatin and other Chinese patent medicines in China.

AnnJi Pharmaceutical

Market Cap: NT$4.4b

Develops drugs in the therapeutic areas of neurology, dermatology, and inflammatory disorders.

Zhejiang CONBA PharmaceuticalLtd

Market Cap: CN¥10.7b

Engages in the research, development, production, and sales of pharmaceuticals and health products in mainland China.

Immuno-Biological Laboratories

Market Cap: JP¥4.5b

Engages in the research, development, manufacturing, and supply of various immunological research reagents worldwide.

Samsung BiologicsLtd

Market Cap: ₩71.2t

Together with its subsidiaries engages in the manufacturing of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.

Neuland Laboratories

Market Cap: ₹179.0b

Engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.

Lumosa Therapeutics

Market Cap: NT$48.2b

A clinical-stage pharmaceutical company, develops therapies and solutions for neurological and oncological diseases in Taiwan, Asia, the Americas, and Europe.

Venus Remedies

Market Cap: ₹5.9b

Engages in the pharmaceutical business in India and internationally.

WuXi Biologics (Cayman)

Market Cap: HK$158.7b

An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia.

Celltrion

Market Cap: ₩39.2t

A biopharmaceutical company, engages in the development, production, and sale of various therapeutic proteins for the treatment of oncology diseases.

Shijiazhuang Yiling Pharmaceutical

Market Cap: CN¥26.4b

Shijiazhuang Yiling Pharmaceutical Co., Ltd.